General
Preferred name
FLUTAMIDE
Synonyms
SCH 13521 ()
FLUTAMIDE13311-84-7 ()
SCH-13521 ()
Eulexin ()
NSC-215876 ()
Chimax ()
Drogenil ()
Flutamide-d7 ()
P&D ID
PD001517
CAS
13311-84-7
337962-98-8
223134-72-3
Tags
available
prodrug
drug
Approved by
FDA
First approval
1989
Drug Status
investigational
approved
Drug indication
Prostate cancer
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Flutamide is an androgen receptor antagonist.
(GtoPdb)
DESCRIPTION
PPARalpha agonist
(Tocris Bioactive Compound Library)
DESCRIPTION
Non-steroidal androgen receptor antagonist
(Tocriscreen Plus)
DESCRIPTION
Non-steroidal anti-androgen
(LOPAC library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
7
Organisms
2
Compound Sets
35
AdooQ Bioactive Compound Library
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
Guide to Pharmacology
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
NURSA ligand set
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Plus
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
42
Properties
(calculated by RDKit )
Molecular Weight
276.07
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
1
Aromatic Ring Count
1
cLogP
3.21
TPSA
72.24
Fraction CSP3
0.36
Chiral centers
0.0
Largest ring
6.0
QED
0.68
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Nuclear Receptors
Selectivity
Androgen
MOA
Androgen Receptor antagonist
Antagonist
Androgen Receptor Antagonists
Target
Androgen Receptor
AHR, AR
Pathway
Endocrinology/Hormones
Vitamin D Related/Nuclear Receptor
Primary Target
Androgen Receptors
Member status
member
Indication
prostate cancer
Therapeutic Class
Anticancer Agents
Source data